Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract

BJU International

Volumn 97, Issue 6, 2006, Pages 1322-1326

  Ohtsuka, Yukihiro ^a   Kawakami, Satoru ^a   Fujii, Yasuhisa ^a   Koga, Fumitaka ^a   Saito, Kazutaka ^a   Ando, Noboru ^a   Takizawa, Touichiro ^a   Kageyama, Yukio ^a   Kihara, Kazunori ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Prognosis; Uroplakin III; Urothelial carcinoma of upper urinary tract

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KAPLAN MEIER METHOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEPHROURETERECTOMY; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; TISSUE DIFFERENTIATION; UNIVARIATE ANALYSIS; URINARY TRACT; URINARY TRACT CARCINOMA; UROTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODE EXCISION; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 33745203723     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06158.x     Document Type: Article

References (17)

1. Saito K, Fujii Y, Kawakami S et al. Increased expression sialyl-Lewis A correlates with poor survival upper urinary tract urothelial cancer patients Anticancer Res 2003 23: 3441 6
2. Badalament RA, O'Toole RV, Kenworthy P et al. Prognostic factors in patients with primary transitional cell carcinoma of the upper urinary tract. J Urol 1990 144: 859 63
3. Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 1998 52: 594 601
4. Konety BR, Getzenberg RH. Urine based markers of urological malignancy. J Urol 2001 165: 600 11
5. Moll R, Wu XR, Lin JH, Sun TT. Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas. Am J Pathol 1995 147: 1383 97
6. Wu RL, Osman I, Wu XR et al. Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formation. Cancer Res 1998 58: 1291 7
7. Olsburgh J, Harnden P, Weeks R et al. Uroplakin gene expression in normal human tissues and locally advanced bladder cancer. J Pathol 2003 199: 41 9
8. Mostofi FK, Sobin LH, Torloni H. Histological typing of urinary bladder tumors, no. 10. International Histological Classification of Tumors. Geneva: World Health Organization, 1973
9. Sobin LH, Wittekind CH. TNM Classification of Malignant Tumors, sixth edition. New York: Wiley-Liss, 2002: 196 8
10. Kaufmann O, Volmerig J, Dietel M. Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas. Am J Clin Pathol 2000 113: 683 7
11. Liang FX, Riedel I, Deng FM et al. Organization of uroplakin subunits: transmembrane topology, pair formation and plaque composition. Biochem J, 2001 355: 13 8
12. Lobban ED, Smith BA, Hall GD et al. Uroplakin gene expression by normal and neoplastic human urothelium. Am J Pathol 1998 153: 1957 67
13. Park S, Hong B, Kim CS, Ahn H. The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract. J Urol 2004 171: 621 5
14. Morioka M, Jo Y, Furukawa Y et al. Prognostic factors for survival and bladder recurrence in transitional cell carcinoma of the upper urinary tract. Int J Urol 2001 8: 366 73
15. Koga F, Kawakami S, Fujii Y et al. Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. Clin Cancer Res 2003 9: 5501 7
16. Ro JY, Staerkel GA, Ayala AG. Cytologic and histologic features of superficial bladder cancer. Urol Clin North Am 1992 19: 435 53
17. Takahashi T, Kakehi Y, Mitumori K et al. Distinct microsatellite alterations in upper urinary tract tumors and subsequent bladder tumors. J Urol 2001 165: 672 7